Voya Investment Management LLC Trims Stock Position in Liquidia Technologies, Inc. $LQDA

Voya Investment Management LLC trimmed its holdings in Liquidia Technologies, Inc. (NASDAQ:LQDA) by 4.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,738 shares of the company’s stock after selling 831 shares during the quarter. Voya Investment Management LLC’s holdings in Liquidia Technologies were worth $247,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the business. GAMMA Investing LLC increased its holdings in shares of Liquidia Technologies by 65.6% in the 1st quarter. GAMMA Investing LLC now owns 2,961 shares of the company’s stock valued at $44,000 after acquiring an additional 1,173 shares during the period. Valmark Advisers Inc. increased its holdings in shares of Liquidia Technologies by 7.4% in the 1st quarter. Valmark Advisers Inc. now owns 18,641 shares of the company’s stock valued at $275,000 after acquiring an additional 1,283 shares during the period. Bleakley Financial Group LLC increased its holdings in shares of Liquidia Technologies by 6.4% in the 1st quarter. Bleakley Financial Group LLC now owns 25,308 shares of the company’s stock valued at $373,000 after acquiring an additional 1,523 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Liquidia Technologies by 4.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock valued at $556,000 after acquiring an additional 1,700 shares during the period. Finally, Significant Wealth Partners LLC increased its holdings in shares of Liquidia Technologies by 14.1% in the 1st quarter. Significant Wealth Partners LLC now owns 14,396 shares of the company’s stock valued at $212,000 after acquiring an additional 1,780 shares during the period. 64.54% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently commented on LQDA. Jefferies Financial Group initiated coverage on shares of Liquidia Technologies in a report on Friday, August 15th. They issued a “buy” rating and a $43.00 target price on the stock. Raymond James Financial boosted their price objective on shares of Liquidia Technologies from $33.00 to $41.00 and gave the company a “strong-buy” rating in a research note on Wednesday, August 13th. Bank of America dropped their price objective on shares of Liquidia Technologies from $25.00 to $23.00 and set a “buy” rating on the stock in a research note on Wednesday, June 11th. Needham & Company LLC boosted their price objective on shares of Liquidia Technologies from $32.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, August 12th. Finally, Wells Fargo & Company boosted their price objective on shares of Liquidia Technologies from $25.00 to $31.00 and gave the company an “overweight” rating in a research note on Wednesday, August 13th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $32.11.

Liquidia Technologies Price Performance

Liquidia Technologies stock opened at $22.80 on Tuesday. Liquidia Technologies, Inc. has a 52 week low of $9.71 and a 52 week high of $29.94. The company has a quick ratio of 2.41, a current ratio of 2.49 and a debt-to-equity ratio of 9.84. The firm’s 50-day simple moving average is $24.05 and its 200 day simple moving average is $17.88. The firm has a market capitalization of $1.96 billion, a PE ratio of -13.41 and a beta of 0.22.

Liquidia Technologies (NASDAQ:LQDA) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.43) by ($0.06). Liquidia Technologies had a negative return on equity of 232.96% and a negative net margin of 732.17%.The business had revenue of $8.84 million during the quarter, compared to analysts’ expectations of $3.90 million. The company’s revenue was up 141.5% on a year-over-year basis. On average, equities research analysts predict that Liquidia Technologies, Inc. will post -1.51 EPS for the current fiscal year.

Insider Buying and Selling

In other Liquidia Technologies news, Director Raman Singh sold 45,524 shares of the company’s stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $25.81, for a total value of $1,174,974.44. Following the transaction, the director directly owned 31,255 shares in the company, valued at approximately $806,691.55. This represents a 59.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jason Adair sold 26,057 shares of the company’s stock in a transaction dated Thursday, August 28th. The shares were sold at an average price of $27.86, for a total transaction of $725,948.02. Following the completion of the transaction, the insider owned 171,029 shares in the company, valued at approximately $4,764,867.94. This trade represents a 13.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 881,097 shares of company stock worth $23,689,864 in the last 90 days. 30.10% of the stock is currently owned by corporate insiders.

Liquidia Technologies Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).